What is your approach and preferred first line treatment regimen for advanced/metastatic adenosquamous NSCLC?
Answer from: Medical Oncologist at Academic Institution
As with all advanced lung cancer, the answer to this question depends upon molecular characteristics and PDL1 status. I would perform NGS (next generation sequencing) analysis of all adenosquamous cancers (by tissue, and if uninformative, potentially ctDNA testing) as well as PDL1. As I tell all of ...
Comments
Medical Oncologist at Joliet Oncology Hematology Associates Very concise answer, thank you.
Very concise answer, thank you.